IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101. A total of 190 filers reported holding IMPAX LABORATORIES INC in Q1 2018. The put-call ratio across all filers is 0.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2017 | $313,000 | +35.5% | 18,812 | +65.6% | 0.01% | +33.3% |
Q3 2017 | $231,000 | -18.1% | 11,359 | -49.1% | 0.01% | -33.3% |
Q1 2017 | $282,000 | -72.6% | 22,300 | -71.3% | 0.01% | -65.4% |
Q4 2016 | $1,028,000 | +167.0% | 77,612 | +378.2% | 0.03% | +188.9% |
Q3 2016 | $385,000 | -74.5% | 16,230 | -69.0% | 0.01% | -71.9% |
Q2 2016 | $1,510,000 | +67.2% | 52,408 | +85.8% | 0.03% | +39.1% |
Q1 2016 | $903,000 | -3.8% | 28,203 | +28.4% | 0.02% | -11.5% |
Q4 2015 | $939,000 | +116.9% | 21,963 | +78.6% | 0.03% | +73.3% |
Q3 2015 | $433,000 | +4.8% | 12,300 | +36.7% | 0.02% | +25.0% |
Q2 2015 | $413,000 | -5.3% | 9,000 | -3.2% | 0.01% | -14.3% |
Q1 2015 | $436,000 | -64.8% | 9,300 | -76.2% | 0.01% | -67.4% |
Q4 2014 | $1,237,000 | +41.5% | 39,050 | +6.0% | 0.04% | +34.4% |
Q3 2014 | $874,000 | +61.9% | 36,853 | +104.7% | 0.03% | +52.4% |
Q2 2014 | $540,000 | +13.4% | 18,000 | 0.0% | 0.02% | +5.0% |
Q1 2014 | $476,000 | +70.6% | 18,000 | +62.2% | 0.02% | +42.9% |
Q4 2013 | $279,000 | – | 11,100 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Krensavage Asset Management, LLC | 730,817 | $21,062,000 | 7.59% |
Hound Partners | 6,757,558 | $194,753,000 | 5.18% |
Aravt Global | 2,232,500 | $64,341,000 | 4.78% |
Asymmetry Capital Management, L.P. | 70,235 | $2,024,000 | 3.71% |
UNIVERSITY OF NOTRE DAME DU LAC | 66,091 | $1,905,000 | 1.80% |
Orbimed Advisors | 5,886,700 | $169,655,000 | 1.77% |
Pennant Capital Management, LLC | 1,949,569 | $56,187,000 | 1.44% |
SECTOR GAMMA AS | 233,934 | $6,742,000 | 1.28% |
Tygh Capital Management, Inc. | 137,190 | $3,954,000 | 1.11% |
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 555,086 | $15,998,000 | 0.93% |